Develops innovative ophthalmic therapies
NuVision Biotherapies has raised €7.3M across 3 funding rounds from 8 investors, most recently a round in Feb 2026. Based in Nottingham, UK; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
